electroCore (ECOR)

• Market cap: $52.8M
• 1 day: 0.63%
• 5 days: 11.95%
• 1 month: -23.71%
• 3 months: 3.07%
• 6 months: -14.73%
• Year to date: 40%
• 1 year: -13.1%
• 5 years: -57.9%
• 10 years: -97.86%
• Sector: Healthcare
• Industry: Medical Devices

About: electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

Employees: 83